DK0618226T3 - Inhibitorer for ibonucleotid-reduktase fra herpes-vira - Google Patents

Inhibitorer for ibonucleotid-reduktase fra herpes-vira

Info

Publication number
DK0618226T3
DK0618226T3 DK94102680T DK94102680T DK0618226T3 DK 0618226 T3 DK0618226 T3 DK 0618226T3 DK 94102680 T DK94102680 T DK 94102680T DK 94102680 T DK94102680 T DK 94102680T DK 0618226 T3 DK0618226 T3 DK 0618226T3
Authority
DK
Denmark
Prior art keywords
alkyl
nhch
amino acid
ibonucleotide
reductase
Prior art date
Application number
DK94102680T
Other languages
English (en)
Inventor
Robert Deziel
Neil Moss
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of DK0618226T3 publication Critical patent/DK0618226T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK94102680T 1993-03-03 1994-02-23 Inhibitorer for ibonucleotid-reduktase fra herpes-vira DK0618226T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2554093A 1993-03-03 1993-03-03

Publications (1)

Publication Number Publication Date
DK0618226T3 true DK0618226T3 (da) 2000-12-27

Family

ID=21826675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94102680T DK0618226T3 (da) 1993-03-03 1994-02-23 Inhibitorer for ibonucleotid-reduktase fra herpes-vira

Country Status (27)

Country Link
US (1) US5476841A (da)
EP (1) EP0618226B1 (da)
JP (1) JPH08507760A (da)
KR (1) KR960701090A (da)
CN (1) CN1118601A (da)
AT (1) ATE197802T1 (da)
AU (1) AU683450B2 (da)
BG (1) BG99889A (da)
BR (1) BR9406346A (da)
CA (1) CA2157196C (da)
CZ (1) CZ224295A3 (da)
DE (1) DE69426337T2 (da)
DK (1) DK0618226T3 (da)
ES (1) ES2152269T3 (da)
FI (1) FI954048A (da)
GR (1) GR3035295T3 (da)
HU (1) HUT72894A (da)
IL (1) IL108818A0 (da)
LV (1) LV11037B (da)
NO (1) NO953437D0 (da)
NZ (1) NZ262073A (da)
PL (1) PL310447A1 (da)
PT (1) PT618226E (da)
SG (1) SG65553A1 (da)
SK (1) SK106095A3 (da)
WO (1) WO1994020528A1 (da)
ZA (1) ZA941449B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830864A (en) * 1992-03-12 1998-11-03 Boehringer Ingelheim (Canada), Ltd. Antiherpes peptide derivatives having a ureido n-terminus
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
EP1744761A4 (en) * 2004-04-28 2010-01-13 Molecules For Health Inc METHOD FOR THE TREATMENT OR PREVENTION OF RESTENOSIS AND OTHER PROLIFERATIVE VASCULAR DISORDER
EP2030615A3 (en) * 2007-08-13 2009-12-02 ELFORD, Howard L. Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE118785T1 (de) * 1989-07-07 1995-03-15 Bio Mega Boehringer Ingelheim Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten.
JPH03181498A (ja) * 1989-12-07 1991-08-07 Merck & Co Inc ペプチド抗ウイルス剤
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use

Also Published As

Publication number Publication date
NO953437L (no) 1995-09-01
WO1994020528A1 (en) 1994-09-15
DE69426337T2 (de) 2001-05-31
SK106095A3 (en) 1996-02-07
CA2157196C (en) 2000-06-13
HUT72894A (en) 1996-06-28
LV11037A (lv) 1996-02-20
CA2157196A1 (en) 1994-09-15
HU9502570D0 (en) 1995-11-28
KR960701090A (ko) 1996-02-24
ZA941449B (en) 1994-10-14
CZ224295A3 (en) 1996-02-14
ATE197802T1 (de) 2000-12-15
PT618226E (pt) 2001-03-30
AU683450B2 (en) 1997-11-13
GR3035295T3 (en) 2001-04-30
LV11037B (en) 1996-06-20
AU6151694A (en) 1994-09-26
IL108818A0 (en) 1994-06-24
PL310447A1 (en) 1995-12-11
NZ262073A (en) 1997-07-27
EP0618226B1 (en) 2000-11-29
FI954048A0 (fi) 1995-08-29
DE69426337D1 (de) 2001-01-04
BG99889A (en) 1996-02-28
EP0618226A1 (en) 1994-10-05
US5476841A (en) 1995-12-19
BR9406346A (pt) 1996-02-21
JPH08507760A (ja) 1996-08-20
SG65553A1 (en) 1999-06-22
FI954048A (fi) 1995-08-29
ES2152269T3 (es) 2001-02-01
NO953437D0 (no) 1995-09-01
CN1118601A (zh) 1996-03-13

Similar Documents

Publication Publication Date Title
ES2134257T3 (es) Derivado de pirazol.
GB9308957D0 (en) Novel produgs
NZ238455A (en) Antiherpes peptide derivatives having a 1,4-dioxo-c 4 n-terminus;
DK0618226T3 (da) Inhibitorer for ibonucleotid-reduktase fra herpes-vira
AU7872798A (en) 16-ene-vitamin D derivatives
HU9501727D0 (en) Novel pyridone carboxylic acid derivatives
TW208014B (da)
LV10461A (lv) Izosterie peptidu atvasinajumi ar pretherpesa ipasibam
ZA931746B (en) Antiherpes peptide derivatives having a ureido N-terminus